1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Gilead Sciences Clinical Development Profile

  • March 2014
  • 76 pages
  • Industry Standard Research
Report ID: 2440468

Summary

Table of Contents

With a market capitalization greater than $100B, Gilead is fast becoming one of the most influential pharmaceutical companies in the world. ISR’s report provides a thorough analysis of Gilead Sciences’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Gilead’s key products.

How you can use this report:
- Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar/ competing
products.
- For Service Providers: Better prepare your business development activities focused on Gilead. Understand their strategic direction, current and potential clinical development pipeline, and historic trial metrics.

Background and strategy
Gilead Sciences Inc. (NASDAQ:GILD) is considered the world’s largest pure-play biotech with a market capitalization over $125 billion as of March 3rd 2014. Yes, $125 billion, with a “b.” Just to put Gilead’s $125B market capitalization into context, AstraZeneca’s (LON: AZN) market cap is around $50B, Ford’s (NYSE: F) is roughly $60B, Coke’s (NYSE: KO) market cap is $168B, and Bank of America’s (NYSE: BAC) is approximately $170B.

During the Gilead Sciences Q4 2013 earnings conference call on February 4, 2014, chairman and CEO, John Martin called 2013 a very productive year for Gilead. Their marketed products achieved record product sales of $10.8 billion, an increase of 15% year over year. He went on to say that the research and development organization also executed a record number of clinical studies across all therapeutic areas, as well as submitted marketing authorization applications in both hepatitis C and oncology. Also during the Q4 2013 call, Martin announced that top line data from three Phase III studies on ledipasvir/sofosbuvir showed positive results and that they expect to file FDA and European applications this quarter. The FDA previously assigned breakthrough designation to this combination and the European Medicines Agency (EMA) has accepted Gilead’s request for accelerated assessment, a designation that is granted to new therapies and medicines of major public health interest.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.